Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in NAFLD
NCT01654549Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2012
- Primary completion
- Sep 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of omeprazole, amoxicillin, bismuth subcitrate, azithromycin in non-alcoholic fatty liver disease (NAFLD), sponsored by Tehran University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
omeprazoleamoxicillinbismuth subcitrateazithromycin
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT01654549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654549.